Transcode Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Transcode Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2023.
  • Transcode Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 14.7M shares, a 13322% increase year-over-year.
  • Transcode Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 179K shares, a 1003% increase from 2022.
  • Transcode Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 16.2K shares, a 99.8% decline from 2021.
  • Transcode Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8.43M shares, a 81.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 179K +163K +1003% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 16.2K -8.41M -99.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 8.43M +3.79M +81.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 4.64M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.